Intuitive Surgical, Inc. $ISRG Shares Sold by Oak Harvest Investment Services

Key Points

• Oak Harvest Investment Services has reduced its stake in Intuitive Surgical by 36.5%, selling 3,404 shares, leaving it with 5,928 shares valued at approximately $2.94 million.
• Analysts have raised their price targets for Intuitive Surgical, with Truist Financial setting a new price objective of $600 and Citigroup moving theirs up to $650, while maintaining a consensus rating of "Moderate Buy."
• In the latest earnings report, Intuitive Surgical reported $2.19 EPS for the quarter, exceeding expectations and reflecting a 21.4% increase in revenue year-over-year, amounting to $2.44 billion.

Oak Harvest Investment Services reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 36.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,928 shares of the medical equipment provider's stock after selling 3,404 shares during the period. Oak Harvest Investment Services' holdings in Intuitive Surgical were worth $2,936,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in ISRG. Brighton Jones LLC increased its position in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after buying an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG increased its holdings in shares of Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after purchasing an additional 883 shares during the period. Integrated Wealth Concepts LLC increased its holdings in shares of Intuitive Surgical by 14.7% in the fourth quarter. Integrated Wealth Concepts LLC now owns 5,530 shares of the medical equipment provider's stock valued at $2,886,000 after purchasing an additional 709 shares during the period. Kovitz Investment Group Partners LLC increased its holdings in shares of Intuitive Surgical by 4.3% in the fourth quarter. Kovitz Investment Group Partners LLC now owns 7,775 shares of the medical equipment provider's stock valued at $4,058,000 after purchasing an additional 324 shares during the period. Finally, Nebula Research & Development LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $809,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Evercore ISI increased their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Piper Sandler reissued an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Zacks Research lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday. Finally, Citigroup reissued a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Stock Up 1.3%

Intuitive Surgical stock opened at $476.16 on Friday. The firm has a market cap of $170.69 billion, a price-to-earnings ratio of 66.41, a price-to-earnings-growth ratio of 4.99 and a beta of 1.59. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business's 50-day moving average price is $504.42 and its 200 day moving average price is $521.58.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the company earned $1.78 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 2,800 shares of the firm's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares of the company's stock, valued at $9,171,844.80. This trade represents a 13.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,839 shares of company stock valued at $7,896,972 over the last ninety days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.